ALCAM Regulates Mediolateral Retinotopic Mapping in the Superior Colliculus by Buhusi, Mona et al.
Development/Plasticity/Repair
ALCAM Regulates Mediolateral Retinotopic Mapping in the
Superior Colliculus
Mona Buhusi,1 Galina P. Demyanenko,1 Karry M. Jannie,2 Jasbir Dalal,1 Eli P. B. Darnell,1 Joshua A. Weiner,2
and Patricia F. Maness1
1Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, and 2Department of
Biology, University of Iowa, Iowa City, Iowa 52242
ALCAM [activated leukocyte cell adhesion molecule (BEN/SC-1/DM-GRASP)] is a transmembrane recognition molecule of the Ig superfamily
(IgSF) containing five Ig domains (two V-type, three C2-type). Although broadly expressed in the nervous and immune systems, few of its
developmental functions have been elucidated. Because ALCAM has been suggested to interact with the IgSF adhesion molecule L1, a determi-
nant of retinocollicular mapping, we hypothesized that ALCAM might direct topographic targeting to the superior colliculus (SC) by serving as
a substrate within the SC for L1 on incoming retinal ganglion cell (RGC) axons. ALCAM was expressed in the SC during RGC axon targeting and
on RGC axons as they formed the optic nerve; however, it was downregulated distally on RGC axons as they entered the SC. Axon tracing with DiI
revealedpronouncedmistargetingofRGCaxonsfromthetemporalretinahalfofALCAMnullmicetoabnormally lateralsites inthecontralateral
SC, in which these axons formed multiple ectopic termination zones. ALCAM null mutant axons were specifically compromised in medial
orientation of interstitial branches, which is known to require the ankyrin binding function of L1. As a substrate, ALCAM–Fc protein promoted
L1-dependent attachment of acutely dissociated retinal cells and an L1-expressing, ALCAM-negative cell line, consistent with an ALCAM–L1
heterophilic molecular interaction. Together, these results suggest a model in which ALCAM in the SC interacts with L1 on RGC axons to promote
medial extension of RGC axon branches important for mediolateral axon targeting in the formation of retinocollicular maps.
Introduction
Axon guidance is orchestrated through multiple receptor/ligand
interactions. In the projection of retinal ganglion cell (RGC) ax-
ons to the superior colliculus (SC), axons from graded positions
within the retina are mapped to SC targets along anteroposterior
and mediolateral axes, specified by A- and B-class Eph receptors
and Ephrin ligands. It has been suggested that gradients of
EphrinB1 in the SC (high-medial to low-lateral) and EphB2 and
EphB3 on RGC axons (high-ventral to low-dorsal) help to map
the dorsoventral retinal axis to the mediolateral SC (Hindges
et al., 2002; McLaughlin et al., 2003). Conversely, gradients of
EphrinA2 and EphrinA5 in the SC and EphA receptors (EphA5,
EphA6) on RGC axons map the temporonasal retinal axis to the
anteroposterior SC (Feldheim et al., 2000; Yates et al., 2001; Hansen
et al., 2004). EphrinBs are chemoattractants for RGC axons with
elevated EphB (Hindges et al., 2002; McLaughlin et al., 2003),
whereas EphrinAs are repellents for axons with elevated EphA
(Feldheim et al., 2000; Yates et al., 2001; Hansen et al., 2004).
Ephrins and Eph receptors do not fully account for the map,
because the phenotypes of mice with Ephrin or Eph loss-of-
function mutations are not fully penetrant (Feldheim et al., 2000;
Hindges et al., 2002).
Ig superfamily (IgSF) molecule L1 (Maness and Schachner,
2007) is a determinant of retinocollicular targeting, providing
dynamic adhesion to the actin cytoskeleton (Demyanenko and
Maness, 2003; Buhusi et al., 2008). Coupling the L1 cytoplasmic
domain to filamentous actin by reversible binding to ankyrin
(Garver et al., 1997) is required for mediolateral positioning of
RGC axons in the SC (Buhusi et al., 2008). Tyrosine to histidine
mutation of a critical residue in the L1 cytoplasmic domain in
L1(Y1229H) knock-in mice disrupts ankyrin binding, causing
pronounced mediolateral retinocollicular axon targeting errors
(Buhusi et al., 2008). This and other L1 mutations occur in a
human X-linked mental retardation syndrome with optic atro-
phy (Kenwrick et al., 2000).
We investigated the cell adhesion molecule ALCAM (acti-
vated leukocyte cell adhesion molecule/BEN/SC-1/DM-GRASP/
Neurolin) as a potential ligand for L1 in retinotopic mapping.
ALCAM is a transmembrane IgSF implicated in T-cell activation
and cancer cell progression (van Kilsdonk et al., 2008) that is
expressed in developing retina and brain (DeBernardo and
Chang, 1996; Weiner et al., 2004). ALCAM null mice exhibit
photoreceptor ectopias resembling retinal folds in human reti-
nopathies and subtle RGC axon defasciculation within the retinal
nerve fiber layer (Weiner et al., 2004). Although ALCAM or-
thologs have been shown to contribute to RGC axon guidance
within the retina and optic tract of fish (Ott et al., 1998; Diekmann
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and Stuermer, 2009) and chick (DeBernardo and Chang, 1996;
Avci et al., 2004), a role in topographic mapping of RGC axons, in
any species, remains unexplored. We show here that ALCAM is a
novel mediator of topographic targeting of retinal axons, likely by
functioning as a substrate for L1 on incoming RGC axons.
Materials and Methods
Mice. The generation and initial characterization of ALCAM null mice
has been reported previously (Weiner et al., 2004). In this line, the first
exon of the ALCAM gene has been replaced by a cDNA encoding green
fluorescent protein (GFP), resulting in a lack of any detectable ALCAM
transcripts and of the encoded protein. Heterozygotes were intercrossed
to produce wild-type (WT) and homozygous null mutants in the same
litters for analyses. All animals were used according to the Institutional
Animal Care and Use Committee policies of The University of North
Carolina at Chapel Hill and The University of Iowa and in accordance
with National Institutes of Health guidelines.
Axon tracing and analysis. Axonal tracing was performed as described
previously (Simon and O’Leary, 1992; Demyanenko and Maness, 2003).
ALCAM null mutant and WT littermates at postnatal day 0 (P0) to P2 or
P8 –P10 were anesthetized, and anterograde tracing was performed by
focal injection of DiI (Invitrogen) as an 10% solution in dimethylform-
amide or dimethylsulfoxide into the peripheral retina using a Pico-
spritzer II (General Valve) and glass micropipettes (internal diameter, 40
m). After 48 h, mice were anesthetized and perfused transcardially with
4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4. The eye
was inspected to identify the injection site and assess its position in a
given quadrant relative to extraocular muscles (lateral and inferior recti).
The eyes were removed, and incisions were made to demarcate retinal
quadrants. To verify the injection sites and analyze the projection areas,
injected retinas, SC, and inferior colliculus (IC) were whole mounted
onto glass slides and examined by epifluorescence and confocal micros-
copy. Analysis was restricted to mice in which retinal whole mounts
displayed a single DiI injection of appropriate size and positioning rela-
tive to insertion sites of extraocular muscles. The boundaries of the SC
and IC were determined by their characteristic shape and location. Ter-
mination zones (TZs) were verified by their branched appearance and
density at high magnification.
To quantify branch orientation from RGC axons, DiI was injected into
the ventrotemporal (VT) retina of ALCAM null and WT littermates at P2
and analyzed at P3. The SC was divided into three bins along the medio-
lateral axis, relative to an emerging TZ: lateral to TZ, within TZ, and
medial to TZ, as described previously (Hindges et al., 2002). The total
number of labeled axons and branches was counted in confocal Z-stacks,
and medial or lateral branch orientation was recorded for each bin. For
each bin, the number of medial branches minus the number of lateral
branches was divided by the total number of branches to arrive at the
branch directional coefficient (DC). A positive DC indicated more me-
dial than lateral branches, whereas a negative DC indicated more lateral
than medial branches. The mean directional coefficient for each geno-
type was computed and compared by a mixed ANOVA.
To evaluate the distribution of DiI-labeled axons from WT and
ALCAM null littermates entering the SC at P2–P3, after retinal injections
at P1, the entrance zone into the SC was divided into 10 equal bins, four
medial to the principal TZ and six lateral to the TZ, as described previ-
ously (Hindges et al., 2002). The percentage of axons entering the SC in
each bin was determined for each mouse and averaged over groups. The
distribution of axons (expressed as percentage of total for each bin) was
analyzed by a mixed ANOVA.
Dorsoventral pretarget axon sorting. ALCAM null and WT littermates
were analyzed for pretarget sorting of dorsal and ventral RGC axons in
postnatal or adult mice by methods used previously (Plas et al., 2005).
ALCAM mutant and WT littermates at P0 –P1 were anesthetized and
injected with DiI into the ventral retinal quadrant and 1,1-dilinoleyl-
3,3,3,3-tetra-methylindocarbocyanine, 4-chlorobenzenesulphonate (DiA)
into the dorsal retinal quadrant, using a Picospritzer as described for
axon tracing. After 48 h, these mice were perfused with 4% paraformal-
dehyde. For adult mice, DiI and DiA crystals were placed into the dorsal
or ventral retinal quadrants in paraformaldehyde-fixed tissues, followed
by incubation at 4°C for 75 d. Brains from each age were sectioned
horizontally and analyzed for the distribution of DiI- and DiA-labeled
axons in the optic tract located between the chiasm and the delta (before
the LGN) and in the brachium in which axons entered the SC, by meth-
ods described previously (Plas et al., 2005). Positions of RGC axons were
scored for locations in the dorsal, ventral, medial, or lateral quadrants of
the optic tract from confocal images. In some cases, whole mounts of the
SC were imaged to observe the distribution of axons as they passed into
the SC from the brachium.
Labeling and quantifications of RGC projections to the dLGN. WT and
ALCAM/ mice were subdued in a chamber with isoflurane. At P10,
each mouse received an injection of Alexa 488-conjugated cholera toxin
subunit B (green) in one eye and an injection of Alexa 594-conjugated
cholera toxin subunit B (red) in the opposite eye (Alexa Fluors; Invitro-
gen). At P12, mice were perfused with 4% paraformaldehyde, and the
brains extracted, stored in protein-free medium for 24 h, and sectioned at
200 nm. The sections were placed on microscope slides.
Fluorescent images of WT and ALCAM/ mouse brain sections con-
taining the dLGN were examined on a Zeiss Axioplan microscope and
captured using universal gains and exposures on a Zeiss Axiocam color
CCD camera. Unmodified images of the dLGN were analyzed in Adobe
Photoshop using a multi-threshold protocol based on the methods de-
scribed by Torborg et al. (2005). The multi-threshold protocol provides a
range of signal-to-background levels for analysis of the size of the ipsilat-
eral axon area (termed “ipsilateral patch”) relative to the total size of the
dLGN, as well as any overlap between the ipsilateral patch and the con-
tralateral axon targeting area in the dLGN. The pixel areas of the modi-
fied images were measured in NIH ImageJ for each threshold level,
delivering values for both ipsilateral and overlap area. Total dLGN area
was measured by selecting the unmodified contralateral image in NIH
ImageJ and measuring total area. Means of ipsilateral area/dLGN area for
each genotype were compared at each threshold level by the t test (two-
tailed, p  0.05).
Immunofluorescence staining and in situ hybridization. Postnatal mice
(P2 and P9) were deeply anesthetized by isoflurane and decapitated. Eyes
and brain tissues were removed and fixed by immersion in 4% parafor-
maldehyde in PBS at 4°C overnight. For eyes, a 30 gauge needle was used
to puncture the cornea to allow for better penetration of fixative; for the
SC, brains were hemisected, and the front of the cerebral hemisphere was
removed. Samples were cryoprotected in 30% sucrose in PBS at 4°C
overnight, then embedded in Tissue-Tek OCT, snap-frozen in isopen-
tane cooled in a dry ice/ethanol bath, and stored at 80°C. Cryostat
sections (14 m) were blocked with 2.5% bovine serum albumin (BSA)
in PBS with 0.1% Triton X-100, and sections were incubated with pri-
mary antibodies (Ab) [rat anti-L1 monoclonal antibody (mAb), 1:200
(Millipore); 1:100, goat anti-ALCAM AF1172 (R & D Systems); rabbit
anti-EphrinB1 (A-20), 1:100 (Santa Cruz Biotechnology); mouse anti-
neurofilament (NF) mAb SMI-312, 1:1000 (Sternberger Monoclonals);
rabbit anti-GFP Ab, 1:1000 (Invitrogen)] in the same solution at 4°C
overnight. Sections were washed in PBS and incubated for 1 h at room
temperature with secondary antibodies coupled to Alexa 488 or 568 or to
cyanine 3, washed in PBS again, and coverslipped using Gel/Mount
(Biomeda). Control sections were incubated with secondary antibodies
only, and the specificity of the ALCAM antibody (AF1172) was con-
firmed by lack of staining on sections from ALCAM null mice (see Fig. 1).
Images were captured on a Leica DM5000B epifluorescence microscope
using nonoverlapping ET series filters (Chroma Technology). For in situ
hybridization to detect ALCAM or L1 mRNA, sense and antisense probes
were generated from psBluescript SK plasmid containing mouse L1
cDNA (Macias et al., 2002) or a 900 bp fragment of mouse ALCAM
cDNA (Weiner et al., 2004), and hybridization was performed using
digoxigenin-labeled probes as described previously (Bartsch et al., 1994;
Garrett and Weiner, 2009).
Cell adhesion assay. Cell adhesion assays were performed using the
L1-expressing human uveal melanoma cell line MUM2C (Seftor et al.,
2002) or dissociated cells from the ventral or dorsal halves of retinas of
WT mice at P3. MUM2B and MUM2C cell lines were subcloned from a
heterogeneous uveal (iris, ciliary body, and choroid) melanoma tumor
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that had metastasized to the liver (Seftor et al.,
2002). A complete characterization of ALCAM
in these and other uveal melanoma cell lines
will be reported separately (K. M. Jannie and
J. A. Weiner, unpublished observations). Ad-
hesion assays were performed essentially as de-
scribed by Nelissen et al. (2000) and Buhusi et
al. (2008) using chambered glass slides (Nunc).
Slides were coated with poly-D-lysine without
(MUM2C) or with (retinal cells) 3 g/ml fi-
bronectin and then treated with 4 g/ml goat
anti-human Fc-(Fab)2 (Jackson ImmunoRe-
search) in TSM (in mM: 20 Tris, 150 NaCl, 1
CaCl2, and 2 MgCl2, pH 8.0) for 1 h at 37°C.
After blocking with 1% BSA in TSM, slides
were coated with 250 ng/ml ALCAM–Fc (R &
D Systems) in TSM with 1% BSA for 1 h at
37°C. Cells (50,000 cells per chamber) in
serum-free RPMI 1640 medium were plated
and allowed to adhere in quadruplicate on
wells with or without ALCAM–Fc for 2 h at
37°C. Cells were washed twice in TSM with
1% BSA and fixed in 4% paraformaldehyde.
After washing in HBSS, cells were stained
with 10 M bis-benzimide, washed, and
mounted in Vectashield. The number of at-
tached cells in 10 random fields (0.38 cm 2)
was scored under epifluorescence micros-
copy, and the mean  SEM number of
cells per field was calculated. To distinguish
L1-dependent and -independent attachment,
cells were pretreated for 15 min at 4°C with
function-blocking L1 monoclonal antibody
(Neuro4; 20 g/ml; gift from J. Hemperly, Bec-
ton Dickinson, Research Triangle Park, NC) or
normal mouse IgG (20 g/ml), and adhesion
was measured after 2 h at 37°C. Means of ad-
herent cells were compared by Student’s t test
(one-tailed, p  0.05).
Retinal cell adhesion assay was performed
in Mat-Tek glass-bottomed slides essen-
tially as described above for MUM2C cells
with few modifications. Poly-D-lysine-treated
slides were first coated with 3 g/ml human
plasma fibronectin (Invitrogen) at 4°C for
overnight, washed twice in 1 PBS, and then
coated with 4 g/ml goat anti-human Fc-
(Fab)2 (Jackson ImmunoResearch) in TSM
for 1 h at 37°C. After two washes in TSM, the
slides were blocked with 1% BSA in TSM for 30
min at 37°C. Slides were coated with 250 ng/ml
ALCAM–Fc (R & D Systems) in TSM with 1%
BSA for 1 h at 37°C. After two washes with TSM,
Neurobasal-A medium (Invitrogen) was added
to the wells until the cells were ready to be
seeded. Dissociated ventral or dorsal retinal
cells were prepared as described previously
(Buhusi et al., 2008), and 50,000 cells per
chamber were plated in Neurobasal-A medium
containing 1 B27 supplement, 1 N2 sup-
plement, and 50 ng/ml BDNF on ALCAM–Fc
or Fc as substrates. For stimulating retinal cells
with EphrinB1, human EphrinB1–Fc fusion
protein (3 nM; R & D Systems) or normal hu-
man IgG (3 nM) as control were preclustered
with 0.3 nM goat anti-human Fc antibody
(Jackson ImmunoResearch) for 1 h on ice. Pre-
clustered EphrinB1–Fc or normal IgG was
added to the cells before plating. After 24 h,
Figure 1. ALCAM and L1 colocalize on RGC axons proximal but not distal to the eye. Immunostaining was performed on
cryostat sections from P2 WT and ALCAM null retina and optic nerve using antibodies against ALCAM (red) and L1 (green).
Within the nerve fiber layer (nfl) of the retina (A–C) and in the optic nerve as it exits the eye (D–F; sagittal section), ALCAM
and L1 colocalized on RGC axons. In ALCAM null retinae, no staining was observed using the anti-ALCAM antibody (A), but
staining for L1 was unaffected (B, C). ALCAM was also prominent in the nascent inner plexiform layer (ipl; C) and
meninges surrounding the nerve (men; F, I, L). Nuclei were counterstained with DAPI (C). Coronal sections through the
proximal optic nerve (G–I ) and more distal optic nerve (J–L) showed progressively reduced expression of ALCAM but not
of L1. Specificity of ALCAM staining was confirmed by its complete loss from the proximal optic nerve of ALCAM null
mutants (inset in G), despite strong L1 expression (inset in H ). ALCAM was essentially absent from RGC axons as they
crossed the optic chiasm (och; M ) but was expressed in some cells near the chiasm located superficially with respect to the
RGC axons (arrowheads, M ). Scale bars: A–C, 75 m; D–F, 150 m; G–O, 50 m.
15632 • J. Neurosci., December 16, 2009 • 29(50):15630 –15641 Buhusi et al. • ALCAM in Retinotopic Mapping
incubation cells were washed, fixed, stained, and analyzed as described
above for MUM2C cells.
Results
ALCAM is expressed in the developing
retinocollicular pathway
Topographic mapping of RGC axons to coordinates in the SC
begins at approximately embryonic day 14 (E14) in the mouse,
when axons arrive at the anterior SC. Axons subsequently grow
posteriorly across the SC, overshooting their future TZs and cov-
ering the SC completely by P0 (McLaughlin and O’Leary, 2005).
Critical to map formation, overshooting RGC axons branch in-
terstitially at approximately P2 with a mediolateral bias for the
topographically correct location of the future TZ. The map de-
velops from P2 to P10 by a balance of branch attraction and
repulsion mediated by factors, including EphrinB1 and Wnt3
gradients in the SC (Hindges et al., 2002; McLaughlin et al., 2003;
Schmitt et al., 2006). We found previously that ALCAM was first
detectable at E12 in mouse retina on axons of the earliest-
differentiating RGCs and that expression persisted into adult-
hood in large subsets of RGCs and amacrine cells, as well as in the
choroid (Weiner et al., 2004). Here a detailed immunofluores-
cence analysis in WT mice during the major stage of retinocol-
licular targeting (P2) confirmed the prominent expression of
ALCAM on RGC axons in the nerve fiber layer and further
showed that ALCAM colocalized com-
pletely with L1 (Fig. 1A–C). ALCAM was
also expressed in the inner plexiform
layer, in which L1 was not detectable, but
neither protein was expressed in the pro-
liferative neuroblast layer. ALCAM and
L1 continued to be prominently colocal-
ized on RGC axons exiting the eye, as
shown in the proximal optic nerve (Fig.
1D–F). ALCAM labeling was also strong
in the meninges (men) surrounding the
optic nerve (Fig. 1D,G). The specificity of
ALCAM immunoreactivity was con-
firmed by the absence of staining in the
ALCAM null mutant retina (Fig. 1 A)
and optic nerve (Fig. 1G, inset), in
which L1 expression remained strong
(Fig. 1 B, C, H, inset). In contrast to
the pronounced colocalization of AL-
CAM with L1 in RGC axons proximal to
the eye at P2 (Fig. 1G–I ), ALCAM, but
not L1, progressively decreased as axons
approached the optic chiasm (Fig. 1 J–
L). As shown in coronal sections at the
level of the optic chiasm, little or no
staining for ALCAM was seen in RGC
axons, whereas L1 staining was strong
(Fig. 1 M–O). ALCAM remained high,
however, in the meninges and in some
cells superficial to the optic chiasm (Fig.
1 M, arrowheads).
Analysis of mice heterozygous for the
ALCAM mutant allele, in which GFP re-
places the first exon of the ALCAM gene
(Weiner et al., 2004), demonstrated that
ALCAM was expressed by cells intrinsic to
the SC. Staining of the P2 ALCAM/ SC
with antibodies against GFP revealed ex-
pression from the ALCAM locus in many
cells in the SC, located mostly within deep laminae, including the
stratum griseum intermediale (SGI), as well as in the stratum
opticum (SO) and meninges, with less staining in the stratum
griseum superficiale (SGS) (Fig. 2A). Double staining with anti-
bodies to neurofilament (NF) (Fig. 2B) showed that cells express-
ing GFP from the ALCAM locus contact NF-labeled RGC axon
bundles within the SO (Fig. 2C). Double immunostaining with
ALCAM and L1 antibodies (Fig. 2D,E) also showed that L1 was
primarily expressed on axon bundles coursing through several SC
layers and that ALCAM protein could be seen to localize to neuropil
that surrounded and closely apposed the L1-expressing axon bun-
dles but was not prominent in the bundles themselves (Fig. 2F),
consistent with its downregulation on RGC axons distal to the eye
(Fig. 1). Double immunostaining with antibodies against L1 and NF
(Fig. 2J,K) showed that most L1 protein in the SC was found on
axon bundles in the SO (Fig. 2L), as well as in deeper layers; non-
axonal L1 was only observed in the SGS (Fig. 2J).
Double staining of the SC at P2 for ALCAM and EphrinB1
showed that they were extensively colocalized within the neuropil
of the SGC, SO, SGI, and deeper layers of the SC, as well as in the
meninges (Fig. 2G–I). A high-medial/low-lateral EphrinB1 gra-
dient has been documented in cell bodies of radial cells in ven-
tricular zone of the mouse SC by in situ hybridization (Hindges et
al., 2002), and EphrinB gradients have also been reported in the
Figure 2. ALCAM is expressed by cells of the superior colliculus. Immunostaining of P2 WT (D–L) or ALCAM/ (A–C) superior
colliculus using antibodies against ALCAM, GFP (to detect its expression from the ALCAM locus in ALCAM/ mice), NF, L1, or
EphrinB1 is shown in representative coronal cryostat sections. Coordinates for all panels are indicated in B; midline is at or near the
left edge of each panel. GFP expressed from the ALCAM locus [GFP (ALCAMKI)] in heterozygotes labels cell bodies near the SO and in
deeper layers of the SC, including those in contact with NF-labeled RGC axon bundles within the SO (note apposition but little
overlap in the higher magnification merge; C). D–F, In WT SC, ALCAM protein is diffusely distributed throughout the neuropil,
including that innervated by L1-positive axon bundles in the SO; the merged image (F ) shows ALCAM protein adjacent to, but
mostly excluded from, these L1-positive axons. ALCAM and EphrinB1 exhibited extensive colocalization in the SC neuropil (seen as
white staining in the merged panel; I ), although EphrinB1 was more prominent in the upper SGS than was ALCAM (G, H ). J–L, L1
protein was primarily found on NF-positive RGC axon bundles in the SO (white staining in the merged panel; L), although some
NF-negative L1 staining, presumably from intrinsic SC cells, was observed in the SGS (J ). D, Dorsal; V, ventral; M, medial; L, lateral;
men, meninges. The sections in A–F are from the rostral SC; those in G–L are from approximately midway through its rostrocaudal
extent. Scale bars: A, B, D, E, G, H, 100 m; J, K, 40 m; C, F, I, L, J, 25 m.
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optic tectum of the chick (Braisted et al.,
1997) and Xenopus (Mann et al., 2002), in
which they function in retinotectal map-
ping. A graded pattern of EphrinB1 protein
was not apparent in our immunofluores-
cence staining of the SC. An EphrinB1 pro-
tein gradient may be more difficult to detect
in the superficial layers of the mouse SC by
immunostaining, because of the shallow na-
ture of the gradient, which declines by only
10% across the mediolateral SC axis
(Hindges et al., 2002). At P9, ALCAM im-
munoreactivity in the SC had declined in
most layers of the SC, although it remained
high in the meninges (data not shown).
Consistent with the localization of AL-
CAM protein in the SC, in situ hybridiza-
tion with an ALCAM antisense riboprobe
demonstrated that ALCAM transcripts
were abundant in cells located within the
SC at P2 (supplemental Fig. 1A, available
at www.jneurosci.org as supplemental
material), whereas control labeling with
the sense riboprobe was negative (supple-
mental Fig. 1B, available at www.jneurosci.
org as supplemental material). ALCAM
transcripts decreased to lower levels in the
SC by P9, when retinocollicular mapping
neared completion (supplemental Fig. 1C,
available at www.jneurosci.org as supple-
mental material). In situ hybridization
with an L1 antisense riboprobe showed
relatively low levels of L1 transcripts
within the SC at P2 compared with retinal
ganglion cells in the neural retina at the
same stage (supplemental Fig. 1D–G,
available at www.jneurosci.org as supple-
mental material). Together, these detailed
expression analyses demonstrate that
ALCAM is expressed in the SC during
retinotopic map formation in a pattern
primarily complementary to that of in-
coming L1-positive RGC axons.
Defective mediolateral targeting of
retinal axons in ALCAM null
mutant mice
To investigate a functional role for
ALCAM in synaptic targeting of retinal
axons, projections of RGC axons to the SC
in ALCAM null and WT littermates were
analyzed at P10 –P12, when the retinocol-
licular map resembles its mature form.
The axon tracer DiI was focally injected into the peripheral retina
of live, anesthetized mice at P8, and labeled RGC TZs were ana-
lyzed after 2 d in the SC. DiI injection into the temporal retinal
half of WT mice (10 of 10) labeled a single dense TZ in the
anterior region of the contralateral SC as expected (Fig. 3A,B).
The injection site varied in regard to the precise location and size
within the temporal retinal half and thus could include some
ventrotemporal RGCs. In striking contrast, DiI injection into the
temporal retina of ALCAM null mutant mice revealed aberrant
targeting of RGC axons along the mediolateral axis of the SC with
high penetrance in 12 of 14 cases. Axons from the temporal retina
of ALCAM null mice usually terminated in one or more laterally
displaced ectopic TZs (eTZs), in addition to a normally posi-
tioned TZ in the mid-anterior SC (Fig. 3D–F). Often the ectopic
TZs of ALCAM mutants were slightly malpositioned posteriorly
in the SC as well (Fig. 3E,F). The small anteroposterior shift of
ALCAM mutant axons might arise from competitive interactions
with mutant axons that are displaced laterally within the SC or
else indicate a minor involvement with the EphrinA/EphA sys-
tem, which regulates topographic targeting along the anteropos-
Figure 3. Defective mediolateral retinocollicular targeting in ALCAM null mutants. A, B, DiI injections into the temporal retinal
half (shown in flat mount) of WT mice at P8 labeled a single TZ in the anterior SC when analyzed at P10. C–F, DiI injections into the
temporal retina of ALCAM null mice revealed eTZs displaced to lateral posterior positions in the P10 SC. Higher-magnification
images of the eTZs are shown for each example. G, H, DiI injections into the nasal retina of WT mice resulted in labeling of a single
TZ in the posterior SC. I, J, DiI injections into the nasal retina of ALCAM null mutant mice resulted in normal labeling of a single TZ
in the posterior SC. K, L, DiI injections into the ventral retina of ALCAM null mutant mice resulted in normal labeling of a single TZ
in the medial SC that was elongated in the anteroposterior axis. M, N, DiI injections into the dorsal retina of ALCAM null mutant
mice resulted in normal labeling of a single TZ in the lateral SC. L, Lateral; M, medial; A, anterior; P, posterior; T, temporal; N, nasal;
V, ventral; D, dorsal.
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terior SC axis (Feldheim et al., 2000). In contrast to the observed
defects in SC targeting of temporal axons, the projection of RGC
axons from the nasal retina was not perturbed in ALCAM mu-
tants. Injections of DiI into the nasal retina of ALCAM null mice
(4 of 4) resulted in labeling of a single TZ within the mid-
posterior SC (Fig. 3 I, J), which occurred at the same location as in
WT SC (4 of 4) (Fig. 3G,H).
Projections of RGC axons originating in the ventral or dorsal
retina of ALCAM null mutant mice terminated normally within
the SC. Ventral retinal injections in ALCAM null mice (9 of 9)
resulted in labeling of a single TZ within the extreme medial SC
(Fig. 3K,L), similar to WT mice (4 of 4; data not shown). Elon-
gation of the ventral retinal projection along the anteroposterior
axis occurred in both WT and mutant mice and was more appar-
ent with injections that included ventrotemporal RGCs. This
elongation was shown previously for WT ventrotemporal axons
and corresponded to the binocular vision field in which ipsilat-
eral and contralateral projections terminate (Plas et al., 2005).
Projections of RGC axons from the dorsal retina of ALCAM mu-
tant mice to the lateral SC was also similar to WT. Dorsal retinal
injections in ALCAM/ mice (6 of 6) resulted in labeled TZs in
the lateral SC (Fig. 3M,N), as also observed in WT (4 of 4; data
not shown) (Buhusi et al., 2008).
The percentage of ALCAM nulls whose temporal axons ter-
minated in abnormally positioned TZs was significantly greater
than WT ( 2  18.66, p  0.00003) (Fig. 4). Although most
ALCAM mutants (11 of 14) had a correctly positioned TZ con-
nected to one or more eTZs, one ALCAM mutant (1 of 14) had a
single laterally displaced eTZ with no normally positioned TZ.
Two ALCAM mutants (2 of 14) had a normal TZ in the medial SC
that was similar to WT. A schematic representation of the
location of TZs of ALCAM knock-out mice shows the termi-
nation positions of temporal axons from ALCAM null mice
that had one correct TZ connected to at least one laterally
displaced eTZ (Fig. 4).
Loss of ALCAM impairs the orientation of retinal axon
branches during establishment of the retinotopic map
To investigate the mechanism responsible for the formation of
ectopic termination zones of RGC axons in the ALCAM mutant
SC, the development of the contralateral retinocollicular projec-
tion was analyzed in mutants and WT littermates. RGC axons
from different parts of the retina respond to the mediolateral SC
gradient of EphrinB1 specified by relative levels of EphB recep-
tors in RGC axons and EphrinB1 in the SC (McLaughlin et al.,
2003). It has been suggested that branches arborize when attrac-
tive and repulsive forces are balanced, thus allowing formation of
TZs (McLaughlin et al., 2003). RGC axons from the VT retina at
P2–P3 project more medially to the anterior SC than purely tem-
poral axons; thus, defects in mediolateral targeting would be
most apparent in these axons. Therefore, we performed DiI in-
jections into WT and ALCAM null temporal retina at P2, selected
injections in which VT axons were preferentially labeled, and
analyzed interstitial axon branches in the SC at P3. DiI labeling of
WT VT retinal axons showed retinal axons and their branches
developing within the anterior SC, including some that were lo-
cated laterally (Fig. 5A). Interstitial branches extending from
WT RGC axons in the lateral SC were preferentially oriented
in the medial direction (Fig. 5B, arrows). Branches extending
from WT VT axons in the medial SC tended to be oriented
laterally (data not shown). In contrast, DiI labeling of VT
axons in ALCAM null mice appeared to be more broadly dis-
tributed across the mediolateral axis of the anterior SC (Fig.
5C), and many axons in the lateral SC had interstitial branches
that tended to be directed laterally, away from a correct loca-
tion for the TZ (Fig. 5D, arrows).
To quantitatively evaluate axon branch orientation in WT and
ALCAM mutant mice, the SC was divided into three bins along
the mediolateral axis relative to the location of the emerging TZ:
lateral to TZ, within TZ, and medial to TZ (Fig. 6A). The total
number of labeled axons and branches was measured, and medial
or lateral branch orientation was scored for each bin (Fig. 6A,B).
Results were expressed as the directional coefficient (DC) as de-
fined previously (Hindges et al., 2002), which was calculated by
subtracting the number of lateral branches from the number of
medial branches and dividing by the total number of branches. A
positive DC indicated more medial than lateral branches,
whereas a negative DC indicated more lateral than medial
branches. This analysis clearly revealed that interstitial VT axon
branches of WT mice (n  10) preferentially oriented along the
mediolateral axis toward the future correct TZ. The majority of
branches in the lateral bin were oriented medially toward the TZ,
branches in the TZ bin were primarily unbiased, and branches in
the medial bin tended to be oriented laterally toward the TZ (Fig.
6A,B). In striking contrast, many VT axons of ALCAM mutants
(n  9) in the lateral bin and the TZ bin had branches oriented
laterally with respect to the correctly located TZ, whereas
branches of axons in the medial bins were normally oriented.
Comparison of DCs by a mixed ANOVA in WT mice (n  10
mice; 650 branches) and ALCAM mutant mice (n  9 mice;
1076 branches) showed a significant main effect of genotype
(F(1,17)  81.9, p  0.001), demonstrating that branch orien-
tation in ALCAM mutant mice was different from WT. Anal-
ysis of the interaction between bin and genotype indicated a
significant difference in branch orientation of WT and mutant
axons in the lateral bin (F(1,17)  125.2, p  0.001) and TZ bin
(F(1,17)  8.6, p  0.01) but not the medial bin (F(1,17)  0.4,
p 	 0.55). These results demonstrate that loss of ALCAM
alters VT axon branch directionality in the SC, such that they
are not effectively oriented medially, a function known to
depend on L1–ankyrin association (Buhusi et al., 2008).
To evaluate whether disruption of ALCAM resulted in altered
patterns of axonal location in the anterior SC that might reflect
axon entry, the distribution of DiI-labeled VT axons entering the
SC was evaluated at P2–P3, after retinal injections at P1. For each
Figure 4. Abnormally positioned termination zones of temporal RGC axons in ALCAM null
mutants. Left, Percentage of WT (n  10) and ALCAM null mutant (n  14) mice with abnor-
mally positioned TZs in the SC after DiI injections into the temporal retina at P8 and analysis at
P10. Right, Schematic diagram of the location of TZs (open circles) and aberrant (single dis-
placed or multiple) eTZs (filled circles) in ALCAM null mice. The centers of TZs and eTZs from
mutant mice (n  14) are marked and connected. The range of location of TZs of WT axons in
the SC is depicted by the dotted oval. L, Lateral; M, medial; A, anterior; P, posterior.
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mouse, the entrance zone of the SC was
divided into 10 equal bins: four bins lo-
cated medial and six bins lateral to nor-
mally positioned TZs (Fig. 6C). Axons
were scored in each bin of WT mice (n 
9 mice; 457 axons) and ALCAM null
mice (n  7 mice; 425 axons), percent-
ages were calculated, and means were
analyzed by a mixed ANOVA. There was
a significant difference in the distribu-
tion of axon entrance between WT and
ALCAM null mice when all bins were
analyzed (F(9,126)  83.44, p  0.001).
Axons of WT mice preferentially en-
tered the SC in the vicinity of the normal
ventromedial TZ site (F(9,72)  8.39, p 
0.001), whereas axons of ALCAM null
mice did not show a statistically signifi-
cant preferential location (F(9,54) 
0.76, p  0.66) (Fig. 6 D). Mann–Whit-
ney tests on individual bins showed sig-
nificant differences between genotypes
in the two bins closest to the normal TZ
location ( p  0.01) and in the extreme
lateral bin ( p  0.05) but not in the
other three bins. This may indicate an
effect of ALCAM on the distribution of
SC axon entry or may simply reflect the
altered branch orientation that other-
wise would start to correct the position
of axons soon after entry into the SC.
Normal pretarget sorting of dorsal
and ventral retinal axons in
ALCAM mutants
Pretarget RGC axon order in the optic
tract contributes to the development
of the retinocollicular map (Simon and
O’Leary, 1992; Hindges et al., 2002; Plas et
al., 2005). Axons from the dorsal and ven-
tral retina are initially segregated at the
optic nerve head, but this order is lost in
the optic nerve and chiasm, reemerging in
the optic tract as axons approach and en-
ter the brachium (entry zone) of the SC
(Plas et al., 2005). Axons from the dorsal and ventral retina
become segregated in the optic tract of the mouse by P1,
whereas axons from the nasal and temporal retina show no
evidence of pretarget sorting at any stage (Plas et al., 2005).
Although the nearly complete downregulation of ALCAM on
RGC axons by the time they reach the chiasm (Fig. 1) suggested
that mapping defects in ALCAM null mutants were unlikely to be
because of defects in pretarget axon sorting, we confirmed this
directly. Dorsal and ventral retinal quadrants of ALCAM mutant
and WT littermates at P0 –P1 were injected with DiA and DiI,
respectively, and the distribution of labeled axons was ana-
lyzed in the optic tract and brachium of the SC after 48 h. In
four of five ALCAM mutant mice, axons from the dorsal and
ventral retina were segregated within the optic tract similar to
WT axons (6 of 6). In the optic tract between the chiasm and
the delta (near the LGN), DiA-labeled dorsal axons (green)
were localized medially, whereas DiI-labeled ventral axons
(red) were localized laterally (Fig. 7). At the brachium of the
SC, dorsoventral axon order switches as the optic tract twists
(Plas et al., 2005). In both WT mice (4 of 4) and ALCAM
mutant mice (4 of 4), dorsal axons were localized laterally, and
ventral axons localized medially at the brachium (data not
shown). In one ALCAM mutant, dorsal and ventral order was
reversed before the delta, but, because the order was normal at
the brachium, this anomaly most likely reflected a slight delay
in reemergence of order after the chiasm. In adult ALCAM
mutants (P28), dorsal and ventral RGC axons were also nor-
mally segregated in the optic tract, with dorsal axons posi-
tioned medially and ventral axons positioned laterally (data
not shown). Furthermore, in ALCAM null mutants, the optic
chiasm was of normal size and morphology and displayed a
prominent contralateral projection and small ipsilateral pro-
jection, typical of WT. No obvious defasciculation was ob-
served in the mutant optic nerve or tract. It should be noted
that photoreceptor ectopias, a phenotype initially observed in
ALCAM null mutants with incomplete penetration (Weiner et
Figure 5. Misorientation of interstitial branches of RGC axons in ALCAM null mutants. WT and ALCAM null mutant RGC
axons were labeled by DiI injection into the VT retina at P2 and analyzed at P3. A, Most branches extending from axons
located lateral to the future TZ were oriented medially, as seen in a higher magnification in B (arrows) from confocal
Z-stacks. C, DiI labeling of VT axons in the SC of ALCAM mutant mice showed abnormal enrichment at a lateral location, as
well as at the appropriate anteromedial location. D, Many interstitial branches of mutant VT axons were abnormally
oriented laterally within the SC (arrows), as shown at higher magnification of the boxed area in C. M, Medial; L, lateral; KO,
knock-out.
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al., 2004), were not observed in ALCAM null mutant mice
after extensive intercrossing onto the C57BL/6 background.
Ipsilateral projections in ALCAM mutant mice
Ipsilateral RGC axons project from the ventrotemporal retina
to the dLGN, in which they form an ipsilateral patch
surrounded by contralateral axon terminations, with the ipsilat-
eral projection occurring at peak stages of E14 –E16 and to a lesser
extent at later stages E17 to P0 (Williams et al., 2006). To visualize
final retinogeniculate targeting and eye-specific segregation, RGC
axons were labeled by injection of cholera toxin B conjugated to
Alexa Fluors (Alexa 488, green; Alexa 594, red) into right or left
eyes of WT and ALCAM null mutant mice at P10 and analyzed at
P12 (Fig. 7F–H). Most mouse ipsilateral projections segregate
into a patch in the dorsomedial dLGN by this stage. The pattern
of ipsilateral projections to the dLGN of ALCAM mutants ap-
peared similar to WT, with little evident overlap with contralat-
eral projections (Fig. 7F,G). Quantification of the area of the
ipsilateral patch relative to the dLGN area, as well as the area of
overlap between the ipsilateral and contralateral areas, was made
by measurement of pixels within designated areas of images using
a multi-threshold protocol (Torborg and Feller, 2004; Torborg et
al., 2005; Bjartmar et al., 2006). There was
no difference in the relative area of the
ipsilateral patch between WT and AL-
CAM mutant mice at any threshold level,
each of which was compared by the t test.
Furthermore, the overlap area relative to
the dLGN area was very small (0.5–2%)
for both genotypes, and there was no sig-
nificant difference between them at any
threshold level.
DiI injections into the ventrotemporal
retina of WT mice at P8 (n  4) and anal-
ysis at P10 showed labeling of a single TZ
in the anteromedial corner of the con-
tralateral SC and an elongated zone in the
medial SC (Fig. 7I), as expected (Plas et
al., 2005). In contrast, ventrotemporal DiI
injections in ALCAM null mutant mice
(n  4) labeled TZs that were laterally
shifted in the contralateral SC as well as
the ipsilateral SC (Fig. 7I). Thus, ipsilater-
ally projecting RGC axons to the SC ex-
hibited a similar mediolateral mapping
defect to contralaterally projecting axons
in the absence of ALCAM.
ALCAM as substrate increases L1-
dependent cell adhesion
The similarity between the phenotype of
L1–ankyrin-deficient mutants (Buhusi et
al., 2008) and that of ALCAM null mutant
mice suggested that mistargeting of retinal
axons could be because of altered L1-
dependent adhesion to ALCAM as a sub-
strate in the SC, resulting in impaired
medial attraction of laterally displaced ax-
onal branches. ALCAM is known to par-
ticipate not only in homophilic (Nelissen
et al., 2000; Neiiendam et al., 2004; Zim-
merman et al., 2004) but also heterophilic
adhesion, for example, to T-cell antigen
CD6 (Bowen et al., 2000; Te Riet et al., 2007), and in chick,
possibly L1 (DeBernardo and Chang, 1996). Attractive re-
sponses of retinal axons to mediolateral guidance cues are
difficult to study in vivo, unlike repellent axon guidance, as
discussed previously (Hindges et al., 2002). However, assays of
adhesion of cells to defined substrates in culture have been
exploited successfully to identify L1- and EphrinB-dependent cellu-
lar mechanisms (Holash and Pasquale, 1995; Buhusi et al., 2008).
To ask whether ALCAM was capable of promoting L1-
dependent cell adhesion as a substrate-bound ligand, we studied
the adhesion of the uveal melanoma cell line MUM2C, derived
from the choroid (Seftor et al., 2002) to purified ALCAM–Fc
fusion protein in vitro. Western blotting showed that MUM2C
cells express L1 (220/200 kDa doublet) but not ALCAM, at both
the protein (Fig. 8A) and transcript (assessed by reverse tran-
scription-PCR; data not shown) levels. As a control for ALCAM
blotting, we included a distinct cell line derived from the same
metastasis as MUM2C (MUM2B), which shows strong expres-
sion of ALCAM but not L1. The L1-positive/ALCAM-negative
MUM2C cells were allowed to adhere to wells coated sequentially
with the Fab2 fragment of anti-human Fc-specific antibody and
with purified ALCAM–Fc fusion protein, and, after 2 h, adherent
Figure 6. Axon branching and positioning in the SC of WT and ALCAM null mice. A, Diagram of directed branch orientation of VT
axons along the mediolateral SC axis at P2. The SC was divided into three bins: lateral (L), TZ, and medial (M), separated by dashed
lines in relation to the forming TZ (shaded circle). The orientation of each branch was scored and graphed by bin. T, Temporal retina;
V, ventral retina. B, Distribution of branches in P2–P3 WT and mutant mice after VT retinal injections with DiI. Arrows depict the
direction of branch preference in each region. Results were expressed as a branch DC as described previously (Hindges et al., 2002).
The DC was calculated in each bin per mouse as the difference in number of medially oriented branches minus laterally oriented
branches, divided by the total number of branches. C, Diagram of RGC axon positions in the SC in WT and ALCAM null mutant mice.
The SC was divided into 10 regions along the mediolateral axis, and labeled axons in each bin were counted and represented
relative to the position of the developing TZ for each injection. D, Distribution of labeled VT axons along the mediolateral SC axis,
expressed as percentage of total axons. * Significant differences in means by a mixed ANOVA, with p values indicated in Results. KO,
Knock-out.
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cells were scored. MUM2C cell adhesion
was significantly increased on the AL-
CAM–Fc substrate compared with the
control, anti-Fc-only substrate (Fig. 8B).
To determine whether enhanced adhe-
sion to the ALCAM substrate was depen-
dent on cell surface L1, MUM2C cells
were preincubated with a function-
blocking monoclonal antibody (Neuro4)
that recognizes a determinant in the extra-
cellular region of L1 required for cell– cell
interactions (Thelen et al., 2002) or with
normal IgG as a control. L1 antibodies re-
duced cell adhesion on ALCAM–Fc to lev-
els on control anti-Fc substrate. Addition
of normal IgG had no effect on adhesion
to ALCAM–Fc or anti-Fc. Thus, ALCAM
presented as a substrate increased L1-
dependent adhesion of the ALCAM-nega-
tive MUM2C melanoma cell line.
To determine whether retinal cells dis-
played increased adhesion to ALCAM–Fc,
cells from the ventral or dorsal halves of
WT retinas (P3) were plated on ALCAM–Fc
or control anti-Fc together with fibronec-
tin, a substrate present on radial glia in the
tectum/SC (Stettler and Galileo, 2004),
and assayed for adhesion after 24 h. Adhe-
sion of both ventral and dorsal retinal
cells was significantly increased on the
ALCAM–Fc substrate compared with the
control substrate (Fig. 8C). To determine
whether EphrinB1 altered adhesion, pre-
clustered EphrinB1–Fc (or control non-
immune IgG) was added to cells before
plating on the ALCAM–Fc substrate.
EphrinB1–Fc increased adhesion of ventral
retinal cells, which express higher levels of
EphB receptors than do dorsal retinal cells
(Fig. 8C). EphrinB1 did not increase adhe-
sion of dorsal retinal cells to ALCAM–Fc
but instead decreased their adhesion.
EphrinB1-induced decrease in adhesion
of dorsal retinal cells to ALCAM might
reflect changes in intracellular signaling
because of different levels of EphB recep-
tors, because it has been shown that EphB
signaling increases or decreases cell adhe-
sion depending on the state of receptor
clustering (Stein et al., 1998; Huynh-Do et
al., 1999; Pasquale, 2005). A caveat is that,
unlike RGC growth cones within the SC
or MUM2C cells, dissociated retinal cells
express ALCAM on the surface, which can
mediate homophilic adhesion to the AL-
CAM substrate. Furthermore, reverse
signaling from EphrinB1, which is likely
to occur in SC cells, would not be mea-
sured in this assay. In any case, these in vitro results suggest
that ALCAM can mediate heterophilic adhesion via L1, in-
creasing the adhesion of retinal cells, and that EphrinB1 pref-
erentially enhances ALCAM-dependent adhesion of ventral
retinal cells.
Discussion
Analysis of ALCAM null mice has identified this IgSF recognition
molecule as a new mediator of retinotopic mapping important
for mediolateral targeting of RGC axon subpopulations in the SC.
Loss of ALCAM caused RGC axons from the temporal retinal
Figure 7. Normal pretarget sorting of dorsal and ventral retinal axons in the optic tract and ipsilateral projections in ALCAM null
mutants. A, C, Location of paired injections of DiI and DiA into ventral (V; DiI, red) and dorsal (D; DiA, green) retinal quadrants of WT
and ALCAM mutant mice at P0, as shown in flat mounts. B, D, Horizontal sections through the optic tract located between the optic
chiasm and delta of WT and ALCAM mutant mice at P2 showed spatial segregation of DiI and DiA, indicating normal sorting of
dorsal and ventral retinal axons in ALCAM null mice. The optic chiasm would be located rostrally and the delta located caudally with
respect to the sections shown in B and D (refer to diagram E). D, Dorsal; V, ventral; M, medial; L, lateral; R, rostral; C, caudal. Scale
bar, 125 m. E, Diagram of anatomical features of the mouse retinal axon projection. OT, Optic tract; vLGN and dLGN, ventral and
dorsal lateral geniculate nucleus of thalamus. F, G, Overlaid images of retinogeniculate projections in WT (F ) and ALCAM/ (G)
mice at P12, displaying similar phenotypes for mapping of ipsilateral (F, green; G, red) and contralateral (F, red; G, green) axons in
the dLGN. H, Quantification of the percentage of dLGN area occupied by the ipsilateral patch in ALCAM/ versus WT mice at P12.
Data are represented as mean  SEM. There were no statistically significant differences ( p 	 0.05, two-tailed t test) between
ALCAM null (n  5) and WT (n  5) mice for all threshold levels. I, Defective mediolateral targeting of ipsilateral RGC axon
projections in ALCAM null mutants. Top, DiI injections into the ventrotemporal retina of WT mice at P8 labeled a single TZ in the
anteromedial corner of the contralateral SC and a diffuse zone in the medial SC when analyzed at P10. In contrast, ventrotemporal
DiI injections of ALCAM null mutant mice labeled TZs that were laterally shifted in both the contralateral SC and ipsilateral SC.
Representative images are shown for WT (n  4) and ALCAM null mutant (n  4) mice.
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quadrant to terminate abnormally at laterally displaced ectopic
TZs in the SC and disrupted the orientation of interstitial RGC
axon branches required for correct mediolateral mapping. Dur-
ing development of the retinocollicular projection, ALCAM was
expressed in cells of the SC and on RGC axons proximal to the eye
but not on the distal part of L1-expressing retinal axons entering
the SC. The expression pattern, ability of ALCAM to promote cell
adhesion through L1 in cell culture, and similarity of retinocol-
licular targeting defects in ALCAM null, EphB, and L1-mutant
mice support a mechanism in which ALCAM on the surface of SC
cells functionally interacts with L1 on retinal axons to promote
directional axon branch orientation toward the medial-high
EphrinB1 gradient in the SC.
The ALCAM null retinocollicular map was remarkably similar
to that of L1(Y1229H) (Buhusi et al., 2008), EphB2/B3 null,
and EphB2 ki/ki (kinase inactive) forward-signaling mutant mice
(Hindges et al., 2002). In each of these mutants, axons from the
temporal retina terminate in prominent laterally shifted TZs in
the SC (with smaller posterior shifts) and exhibit a decreased
preference in medial orientation of interstitial axon branches
during mapping. Attraction of interstitial RGC axon branches
toward EphrinB1 in the medial SC requires tyrosine kinase sig-
naling from EphB receptors (Hindges et
al., 2002; McLaughlin et al., 2003), as well
as L1 linkage to the actin cytoskeleton
through ankyrin (Buhusi et al., 2008).
ALCAM as a substrate in the SC might
engage L1 on RGC axons directly or indi-
rectly to promote transient adhesive con-
tacts in growth cones necessary for medial
attraction of axonal branches. In accord
with this possibility, purified ALCAM–Fc
fusion protein potentiated adhesion of
retinal cells in culture and increased adhe-
sion of an L1-positive, ALCAM-negative
uveal melanoma cell line in an L1-
dependent manner. Because the forma-
tion of laterally directed interstitial
branches was unaffected in ALCAM mu-
tants, ALCAM does not appear to be in-
volved in the repellent counterforce
mediated by Wnt3/Ryk (Schmitt et al.,
2006).
A functional L1–ALCAM interaction
mediating retinal branch extension is in
accord with in vitro studies showing
that the chick ortholog of ALCAM (DM-
GRASP/BEN) promotes retinal axon
growth dependent on the ortholog of L1
[NgCAM (neuron– glia cell adhesion
molecule)] (DeBernardo and Chang,
1996; Avci et al., 2004). ALCAM in the SC
might interact with L1 on RGC axons di-
rectly or indirectly through a distinct co-
receptor on retinal axons. However, such
a receptor is unlikely to be CD6, because
this molecule is not detectable in the ret-
ina or SC (Bowen et al., 2000) (J.A.W.,
unpublished data). Although ALCAM did
not coimmunoprecipitate with L1 from
lysates (1% NP-40) of neonatal mouse
retina or brain (data not shown), an inter-
action between these molecules could be
transient, low in affinity, or simply difficult to demonstrate in the
absence of normal membrane topology. Eye enucleation experi-
ments suggested that L1 was not present in the retino-recipient
layer of the hamster SC (Lyckman et al., 2000), but we did detect
L1 transcripts in a nongraded pattern in mouse SC, although at
levels much lower than those observed in RGCs. Thus, L1 on
RGC axons might bind ALCAM within the SC in trans or ho-
mophilically bind to L1 in a cis-interacting complex with ALCAM
on the SC cell surface.
Mistargeting of retinal axons in ALCAM mutant mice did not
appear to result from an impairment of intra-retinal pathfinding.
ALCAM null mutants displayed a few misrouted axons within the
retina and showed subtle effects of defasciculation, but most ax-
ons grew normally to the optic disc (Weiner et al., 2004). In this
regard, mammalian ALCAM may function differently from Neu-
rolin, the fish homolog of ALCAM, which mediates intra-retinal
RGC axon pathfinding (Ott et al., 1998) and guidance in the optic
tract (Diekmann and Stuermer, 2009). Alternatively, there may
simply be higher redundancy of IgSF members in mammalian
RGC axon pathfinding. In any case, ALCAM was not essential for
retinal axon outgrowth in mice per se, because the optic nerve
and tract of null mutants was normal in size, and axons entered
Figure 8. ALCAM as substrate increases L1-dependent adhesion of MUM2C and retinal cells in culture. A, Western blotting of
MUM2B and MUM2C cell extracts (30 g) with antibodies to L1 and ALCAM and -tubulin as a loading control. B, MUM2C cell
adhesion onto anti-human Fc-(Fab)2 with or without ALCAM–Fc substrates was quantified by determining the mean number of
cells per field from three or more assays. Adhesion of MUM2C cells to ALCAM–Fc substrate (with anti-Fc) was significantly greater
than adhesion to anti-Fc alone. Adhesion of MUM2C cells to control anti-Fc or ALCAM–Fc (with anti-Fc) substrates was unaffected
in the presence of normal IgG (NIgG; 20 g/ml). MUM2C adhesion to ALCAM–Fc (with anti-Fc) was significantly decreased in the
presence of L1 function-blocking antibodies (Neuro4 mAb, 20 g/ml) but not normal IgG. *p  0.05, statistical significance by
Student’s two-tailed t test; SEM. C, Adhesion of dissociated retinal cells from ventral (black bars) or dorsal (gray bars) hemiretinae
of WT P3 mice was increased on an ALCAM–Fc substrate (with anti-Fc and fibronectin) compared with a control substrate (anti-Fc
with fibronectin). Preclustered EphrinB1–Fc increased adhesion of ventral retinal cells to ALCAM–Fc compared with cells treated
with normal IgG (NIgG). EphrinB1–Fc partially decreased adhesion of dorsal retinal cells to ALCAM–Fc. *p  0.05, statistical
significance by Student’s two-tailed t test.
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the SC at an appropriate stage. In addition, ipsilateral RGC axon
guidance at the optic chiasm, which depends on EphrinB2/
EphB1 interactions (Williams et al., 2006), did not seem to re-
quire ALCAM, because axons projected ipsilaterally at the optic
chiasm and normally targeted the dorsal lateral geniculate nu-
cleus, in which they segregated from contralateral axons. ALCAM
restriction to RGC axon segments before but not after the optic
chiasm may be because of downregulation as a result of defas-
ciculation, which occurs at the chiasm and as axons enter the SC
(Plas et al., 2005). Similarly, zebrafish ALCAM (known as DM-
GRASP), which is expressed on fasciculating segments of motor
axons, is downregulated on defasciculation during innervation of
the muscle target (Fashena and Westerfield, 1999).
Our studies also suggest that ALCAM does not play a critical
role in pretarget sorting of dorsal and ventral axons in the optic
tract and exerts only a minor effect on axon entry or early distri-
bution in the anterior SC. This is in accord with the decreased
expression of ALCAM on distal RGC axons, although it was
present on meninges surrounding the optic nerve and the surface
of the SC. Pretarget sorting of RGC axons is known to be re-
stricted to the dorsoventral axis of the retina (Plas et al., 2005) and
is relatively independent of EphB2/EphB3 (Plas et al., 2008). To-
pographic mapping of temporal and ventrotemporal RGC axons
along the mediolateral SC axis appeared to be more strongly in-
fluenced by axon–target interactions involving ALCAM than was
the mapping of ventral or dorsal axons. Although ventral retinal
axons express high levels of EphB, mediolateral targeting of ven-
tral retinal axons is chiefly determined by pretarget sorting (Plas
et al., 2008). Thus, the observed normal mapping of ventral axons
in the absence of ALCAM would be consistent with a preferential
mechanism of pretarget sorting that is relatively independent of
both ALCAM and EphB. Alternatively, EphB signaling in this
subpopulation of retinal neurons may be qualitatively different
from that in ventrotemporal or temporal retinal neurons, which
express lower levels of EphB, and thus may not influence
ALCAM-dependent adhesion detectably.
Our studies suggest that ALCAM interaction with L1 may
regulate adhesion in response to EphrinB/EphB signaling to pro-
mote directional branch extension of RGC axons from the tem-
poral retina, necessary for topographic mapping along the
mediolateral SC axis. Signaling through EphB2/EphB3 in retinal
axons might modulate L1 phosphorylation on Tyr1229, altering
ankyrin binding, cytoskeletal engagement, and adhesion to
ALCAM. Because ALCAM is prominently expressed not only in
the visual system but also in other axonal projections, such as
spinal cord pathways (Fashena and Westerfield, 1999; Arancio et
al., 2001; Dillon et al., 2005), ALCAM may have a broader role in
L1-dependent synaptic targeting, vital to establishment of con-
nectivity in multiple regions of the developing nervous system.
Future studies will be aimed at exploring ALCAM–L1 genetic and
physical interactions in other axonal projections during brain
development.
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